chrisvoncsefalvay/vaers-outcomes huggingface dataset:
? At approximately 6:50PM vaccine was administered.  ? Within 10 minutes of the dose being administered, patient began vomiting.  ? At approximately 7:03PM, RN attempted to assess patients pulse. RN determined pulse to be approximately 100 BPM but was difficult to be confident as the pulse was indistinct. Another RN also attempted to collect a pulse and was not confident in a reading. Oxygenation and heart rate was attempted to be collected using a pulse oximeter. A reading could not be determined. Additionally, a temperature could not be collected using an infrared thermometer. Upon observation, the patient appeared pale and diaphoretic. He did not present or report difficulty breathing at any time. Patients skin was cool to the touch. Patient reported to his parents that he felt nauseous and cold.  ? At approximately 7:08PM patient was offered juice. ? At approximately 7:10PM RN observed that nail bed began to become discolored, slightly blue. RN requested call 911. ? EMS onsite by 7:15PM. EMS vitals included, o BP 131/88 o HR 103  o Resp. 24  o O2 Sat 98% o Temp 98.4 ? Family declined glucose screen and transport to emergency department as patietn began to report feeling better. Patients color improved. ? EMS, family, and staff left scene at approximately 7:50PM.  ? RN connected with patients father on 7/16/21. Father reported that patient was doing much better, slept through the night with no issues. Patient was still sleep when father left for work that morning, however, father looked in on him. Per fathher, his color appeared good and he was sleeping well. Father wondered what gauge needle was used for the procedure. He stated he thought is was long and perhaps a 1 ½ ? size. RN assured it was a 1? needle as the type of set-up used was a complete set-up with a standard 1? needle.
Pt was due to be discharged after undergoing cardiac catherization.  Per chart, pt became restless and nonverbal 5-10 minutes after receiving pneumonia and influenza vaccine. Pt "passed out." Pt also variously decribed to have HA, tongue numbness, and to be diaphoretic and anxious.  Pt then reported trouble seeing.  CT scan subsequently revealed a CVA. 10/7/09 Medical records an DC summary received for dates 12/25/08 to 1/14/09. DC DX: Hypertensive heart disease, heart failure. Secondary DX: Cerebral embolism w/ infarction, anaphylactic shock, unspecified hemiplegia, systolic heart failure/CHF, coronary atherosclerosis, adverse affect of viral vaccine, low potassium, BPH, urinary obstruction, cataracts, homonymous hemianpsia.  Presenting SX: In ER c/o abdominal pain, worsening constipation, chest pain, and SOB, difficulty with speech past 3 days. Assessment: jugular venous distention, systolic murmur, irregular heartbeat, bi-lateral lung crackles, abdominal distention, tenderness, +BS, neuro exam WNL. Pt had cardiac cath completed w/o incident. At some point during inpatient pt had CVA. CT on 1/4/09 results, development of a large intraparenchymal hemorrhage in the right temporal and parietal lobes with significant surrounding edema and resultant right to left subta-cine and transtentoria herniation. Craniotomy performed for a right intraparenchymal hematoma converted to hemorrhage, right frontotemporal craniotomy for evacuation of hematoma, placement of ventricular drain. Pt sent to rehab facility 1/14-2/7/09 had PT and OT, speech therapy. Pt DC home and f/u with PC.
A few days after the injection I was hanging pain from the site injection. Now it?s four months later and I still have  a stabbing pain in the exact location of my shot. This occurs at least 5-6 times a day.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No medical history, concomitant medications or drug reactions/allergies were reported. Sometime in 2011, the patient was vaccinated with the GARDASIL first dose (lot number, expiration date, route and site not reported). Now (on approximately 01-JUL-2013), the patient was in the office to receive dose 2 of GARDASIL which would be late. Additionally, no symptoms were reported. Additional information is not expected.
This case was reported by a physician via sales representative and described the occurrence of not responding to therapy in a subject of unspecified age and gender who was vaccinated with Hepatitis B vaccine (manufacturer unspecified). On an unspecified date, the subject received unspecified dose of Hepatitis B vaccine (unknown). At an unspecified time after vaccination with Hepatitis B vaccine, the subject experienced decreased therapeutic response. A physician had inquired via sales representative, whether a subject needed to complete another ENGERIX series or just a booster; if a subject had completed a Hepatitis B vaccine series, but serum titers were drawn, did not show complete immunity. No other information was provided.
1. metallic taste in mouth lasting about one day on day of injection march 25 2. body aches and pains, severe headache, fatigue, stomach distress nausea March 26-28 3. April 5-7 another incidence of fatigue including fever and shaking  4. April 9  a mini-flu type illness including vomiting and shaking/constipation/diarrhea 5. today April 25, metallic taste in mouth again
2 days p/vax pt exp upper respiratory congestion, felt warm. later found pt shaking. temp 104.5f. exam in ER dx w/febrile seizure & URI.
Case number PHEH2014US004179 is an initial spontaneous report received from the nurse on 26 Feb 2014 with the follow-up received on 21 Mar 2014. This report refers to an 18-years-old male patient. Past medical history and concomitant medications were not reported. On 03 Jan 2014 at 3:30, he was vaccinated with intramuscularly with only a partial dose of MENVEO (batch number: A13011) where Men A lyophilized component on MENVEO was reconstituted with an unknown diluent instead of Men CYW-135 liquid component. No adverse event was reported following this maladministration error. Follow-up received from a nurse on 21 Mar 2014: Patient's demographics and time of vaccination updated.
fever 101.7; Sore throat; Headache; do not feel alright; This is a spontaneous report from a contactable consumer reported for self. This patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EK9231) via an unspecified route of administration on 21Jan2021 at single dose for COVID-19 immunisation. Medical history and concomitant medications were not provided. The patient experienced fever, sore throat, headache, do not feel alright in Jan2021. The patient had fever 101.7 and got a little bit of sore throat. The patient had got the headache. The patient wanted to make sure that all of this is normal. The patient worried about the fever more than anything. The patient did not feel alright and fever was going up. The outcome of the event fever was not resolved. The outcome of other events was unknown.
1722-pt went limp for 10-15sec then became  semi-rigid w/arms w/clonic jerks about 5 jerks for 15 to 20 secs; MD was consulted & pt examined & released
Patient developed redness, swelling of his arm to the wrist. Experienced pain. Area warm to touch; Follow up in 2 to 3 days
pt sat down, wanted only her covid vaccine but in addition to her covid vaccine also received the fluarix flu vaccine. pt was upset, did NOT exhibit any side effects post admin.
Patient reports normal state of health yesterday however this morning when she woke up noted bilateral leg weakness leading to multiple fall at home.  Reports chronic back pain but appears to have worsened today in the lumbar region.  Reports some shortness of breath and nausea today.  Also endorses dysuria, patient recently started on Bactrim for UTI currently on day 8 of 14 antibiotic.
have an auto-immune disorder; Caller had shingles after the first dose; mild case of shingles on my chest. It itches a lot; not feeling well; This is a spontaneous report from a contactable consumer (patient).  A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number was not reported), via an unspecified route of administration on 09Apr2021 as 1ST DOSE, SINGLE for covid-19 immunization. Medical history included fibromyalgia, thyroid issues, Hashimoto's disease and a couple other things and she has not taken any medication for it. The patient's concomitant medications were not reported. Patient reported that after first vaccine, around the end of the month and was supposed to get the second one and was not feeling well and was told to wait. On an unspecified date in Apr2021, the patient experienced an auto-immune disorder, caller had shingles after the first dose, mild case of shingles on my chest, it itches a lot, but it didn't pop up until almost 3 weeks after the vaccine. She do have an auto-immune disorder, Is concerned about getting the second vaccine due on 14May2021 and getting the shingles again and if she gets it again she wonders if they can become worse since she is to get the second vaccine at the end of the week. Outcome of all the events was unknown.  Follow-up(12May2021): This is a follow-up spontaneous report from a contactable consumer (patient). This female consumer (patient) reported for herself included the clinical information.  Information on lot/batch number has been requested.
spitting up clear, thick mucous like liquid; tingling; her heart was racing too; a sore arm; chills; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of REGURGITATION (spitting up clear, thick mucous like liquid), PARAESTHESIA (tingling), PALPITATIONS (her heart was racing too), VACCINATION SITE PAIN (a sore arm) and CHILLS (chills) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     The patient's past medical history included Clotting disorder (Rare blood clotting disorder. diagnosed 20 years back.) and Vertigo (diagnosed 20 years back). Concurrent medical conditions included Allergy (Allergic to latex and oxycontin). Concomitant products included LORATADINE and WARFARIN for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced REGURGITATION (spitting up clear, thick mucous like liquid), PARAESTHESIA (tingling), PALPITATIONS (her heart was racing too), VACCINATION SITE PAIN (a sore arm) and CHILLS (chills). At the time of the report, REGURGITATION (spitting up clear, thick mucous like liquid), PARAESTHESIA (tingling), PALPITATIONS (her heart was racing too), VACCINATION SITE PAIN (a sore arm) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
3 hrs p/vax pale, dec responsiness, cyanotic, listless then irritable; adm to hosp -DTP rxn poss sz r/o sepsis;
both my arms became paralyzed, my college roommate had to help me get dressed and carried my tray in the cafeteria for two days
Got up to go to the bathroom in the middle of the night, was dizzy. Wife walked with him because of the dizziness. On way back to bed he passed out and I tried to help ease him down. Came back almost immediately. Got on hands and knees and crawled to bed. Ran a fever of 100.3 all Wednesday and stayed in bed because of dizziness. By Thursday he was fine again and started doing his normal activities.
About 1 1/2 months after my vaccine, I started having a severe headache just over my left eye. The area of pain never moved. About three weeks after that, I still had the headache but also started having a racing heart and palpitations. I went in to an urgent care clinic on November 24, 2021 and it showed my labs were off. My primary care doctor received a copy of my labs and then messaged me and told me to go to the ER if I experienced any problems with dizziness, lethargy. The doctor gave me a referral to a hematologist and rheumatologist. I saw the hematologist on 12-28 and at that time I had burning and very swollen hands and feet with my hands being white and stiff, especially at night. I also had small tender nodules with rash on my lower legs. He ordered CT scan of my chest, neck, abdomen and pelvis as well as ordering labs. He diagnosed me as having erythema nodosum on lower legs. On 1-7-2022 I went to the rheumatologist and she said said it was possible that I was having some kind of post viral hyperactive immune response. She said I needed further workup for Sarcoidosis or other auto immune disease. She ordered bloodwork. I had a telehealth visit with the hematologist on 1-28-2022. He had me take oral iron but I could not tolerate it well so i was given the iron by IV. On April 18, 2022 I went to the local ER with continued burning and pain at joints in ankles, feet and hands and a headache. They prescribed gabapentin but I did not ever start taking that. I did have blood drawn. They suggested neurology on an outpatient basis. I still suffer from headaches, insomnia, burning pain at my joints in my hands, ankles, feet and wrist. I am still having labs drawn periodically due to continued high levels of inflammation markers.
Red rash at injection sight which developed 7 days after vaccine administration. Lasted for 3 days.
Received my first dose 1/16/2021, Received my second dose 2/11/2021 - had no unusual reactions to these doses  Received my booster 11/30/2021 - only had a sore arm and a bit of fatigue following the shot - on 12/9/2021 started breaking out in an itchy rash with hives on my neck and torso.  Has been consistently occurring since 12/09/2021 all over my body at random points throughout the day.  Worsens often at night, in heat, stress, skin contact, sweat, and lack of sleep. Went to dermatologist yesterday, was told I have chronic urticaria.
This case was reported by a physician via sales rep and described the occurrence of sudden infant death syndrome in a 2-month-old patient who received ROTARIX. Co-suspect products included Nystatin unknown for thrush. Concurrent medical conditions included thrush (treated with Nystatin). On 8th March 2017, the patient received the 1st dose of ROTARIX (oral) and Nystatin at an unknown dose and frequency. On 9th March 2017, 1 days after receiving ROTARIX and Nystatin and 1 day after starting ROTARIX and Nystatin, the patient experienced sudden infant death syndrome (serious criteria death and GSK  medically significant). On 9th March 2017, the outcome of the sudden infant death syndrome was fatal. The patient died on 9th March 2017. The reported cause of death was sudden infant death syndrome. The reporter considered the sudden infant death syndrome to be unrelated to ROTARIX and Nystatin. Additional details were provided as follows: On 8th March 2017, in morning, the patient received vaccination with ROTARIX at the physician visit. On the same day, the physician prescribed Nystatin for Thrush of the mouth. It was reported that the patient played all day and was fine. On 8th March 2017, in evening, the patient received a dose of Nystatin. On 9th March 2017, in morning, the patient was found dead. The physician mentioned it was not known if an autopsy was being done but potential Sudden infant death syndrome (SIDS) might be a cause. The sales representative had a little information. The contact details of the reporting physician were provided for the follow up.
Fever of 101.3 across 24 hours, alternating chills and sweats, severe muscle and joint pain and discomfort, fatigue, nausea, loss of appetite.
pregnant at time of vaccination 4weeks Dose 1, fatigue, and cold and developed at end of Dec. 2020 , lab was checked 01/04/2021 TSH was 80  / Free T 4 .7. Synthroid hypo. Thyriod antibodies was positive.  Hashimoto
As entered by RN into Medical Record: Patient stated that she felt dizzy when she stood up. Patient's blood pressure elevated to 130's/100's, down at discharge to 126/92.  Pulse rate was high at 132 about 10 minutes after injection. Patient stated that she had a cardiac ablation done in 2016 and currently takes propranolol BID.  Last dose taken was 0800 with food. Per patients watch HR prior to vaccination was in the 60's. Patient was held for 45 minutes with no change in B/P or pulse rate.  Family Provider notified, per PA have patient monitor for a couple of hours at home if able to drive and return to ER if not any better. Provider instructed patient not to take another dose of her beta blocker at this time. Patient was instructed to call clinic with any other issues.  V/S at discharge 126/92 pulse 120.   Called patient in the evening on 12/29/2020 at 7:30 pm. She stated she did feel better but still had a "jittery" feeling and HR was still in the 120's per her watch reading. No SOA reported. Did report some nausea. Patient did not feel in distress. Instructed in symptoms continued to visit the ER.   12/30/2020 at 0848 visited Medical Center for tachycardia and HTN. Prescribed steroids and metoprolol.
She lost her balance and ability to walk. At first she would bounce off the walls then it turned into her having to be carried, she was unable to stand on her own.  She was admitted to hospital on 10/24/2009 for 5 days. She is still receiving PT and OT. Her treatment currently is IVIG infusions.
Twenty-thirty minutes after receiving Kinrix, MMR, PPD and Varicella vaccines, pt had an episode of vomiting. She then developed an erythematous macular rash on her face, and reported b/l tingling in the feet. A macular papular rash was noted on her trunk 15 minutes later pt remained alert and interactive. Vitals remained stable. There was no respiratory distress, no lip or tongue swelling. BENADRYL was given and symptoms began to reverse in 30-40 minutes pt was sent to the ED because parents were not comfortable taking their daughter home. She was d/c from the ED with in 3-4 hours without further intervention. Parents deny any such event in the past. Currently, pt remains well.
given vaccine 04/15/05 Fri- arm sore, low grade fever. Injection site felt sore. Saturday evening, 4/16-4/17- Fevers high and Sun. 04/17- Had quarter size hives at vaccine site. Went to ER. Given Tylenol, Motrin, IM and PO Benadryl. Steroid injection.
Pt recvd vax & devel severe irritability & crying; No further details were provided;
Woke up at 3am with severe nausea, chills and body aches. Severe nausea felt like food poisoning, but there was nothing to expunge from my stomach because I wasn't really sick. Nausea lasted around 12 hours before I could drink water and eat some crackers. Experienced dizziness for 24 hours if I tried to walk more than 10 steps. Chills lasted 24 hours. Then it would switch from sweats to chills and back again for 48 hours.  Sweats and diarrhea lasted seven days before I felt back to normal. I never registered a fever.
Woke at 3:00am (ish) & was shivering, I was asked by my fiancé was I okay and I stated I was but I stuttering uncontrollably.
43 yo female patient on temporary assignment abroad presented with Ascending Paralysis on 8/17/2017 to the ED via 911. No significant PMH, No recent illnesses reported and no trauma. On arrival she reported feeling some weakness in her lower extremities on 8/15 which progressed to inability to stand on 8/17. She had 5/5 dorsi and plantar flexion but 1/5 hip flexion and extension. No Achilles of patellar reflexes could be elicited. Toes did not fan with Babinski. Exam was benign otherwise.
Large red welt, that the pharmacy was notified about and has continued to grow. Patient used a marker 8/28 to outline it, and it has grown 1/4 inch since yesterday.
Patient has expired vein pain and bruising, in the same place on her leg, post shot on both occasions, over a large varicose vein. Patient today is reporting enlarged breasts, with the right breast larger than the left. It should be noted that patient has had a complete hysterectomy, so hormones and menstrual cycle are not factors. Patient is clinically post menopause, and not on any hormone therapy.  Complete hysterectomy completed 18 years ago.
Patient received Pfizer vaccine at 12:30. Patient began having chest pain 5 minutes after receiving vaccine, as well as complaining of a tickle in his throat. 50mg of Benadryl was administered. Pain in chest increased to a 7/10 pain. Paramedics were called at 12:49. Patient complained that chest pain was worse with breathing. Paramedics arrived at 13:00, took vital signs, and administered a 12 lead EKG. Paramedics did not feel as though a hospital visit was necessary. Assesment of vaccine site shoed no localized reaction, patient denied pain at injection site. No visible signs of redness or rash on arms or torso. Patient was alert and oriented the entire time. 30 minutes following Benadryl administration, the patient stated he was tired. The patient decided he wanted to go home and was picked up by a family member. He was instructed to rest the remainder of the day and to calll 911 if his symptoms worsened.
flu; This is a spontaneous report received from contactable reporter (Consumer). The reporter is the patient.  A 67 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 67 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose), for Covid-19 immunization. The following information was reported: INFLUENZA (non-serious), outcome "unknown", described as "flu".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Headache, Myalgia, Arthralgia, Diarrhea &  NauseaVomiting Narrative:   Other Relevant History:
Pt recvd vax 22AUG92 & 45 mins following vax pt exp heavy chest pains w/in 1 to 2 hrs following vax became sharper; 23AUG92 pt exp severe congestion & had difficulty breathing; following 2 wks cont to exp difficulty breathing w/wheezing;
pt recv vax & w/in min p/vax exp itching & w/in 24hr pt exp raised, red, hard indurated area of 4cm (injections site); ER or MD visit was required;
Rt arm Reddened and swollen to elbow after Pneumonia Vac. Rocephin 1gm IM given and Rx Bactrim DS once BID #20
This case was reported by a healthcare professional, via a sale representative, and described the occurrence of swollen gland in a 41-year-old female subject who was vaccinated with HAVRIX 1440 for prophylaxis. On 30 April 2008 the subject received 1st dose of HAVRIX 1440 (unknown). On 3 May 2008, three days after vaccination with HAVRIX 1440, the subject experienced swollen glands, headache, body pain and low grade fever. The subject was vaccinated at a travel clinic. The reporting travel clinic nurse recommended that the subject be seen at a physician's office. At the time of reporting, the events were unresolved.
Immunized flu and pneumonia same arm 10-01-07. On 10-02-07 patient's arm was imflamed at injection site.  shortness of breath. called ambulance to ER.
a tiny bit of redness; This case was reported by a consumer via call center representative and described the occurrence of erythema in a 78-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In March 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced erythema. On an unknown date, the outcome of the erythema was unknown.   It was unknown if the reporter considered the erythema to be related to Shingrix.  Additional details were provided as follows: After vaccination with Shingrix, the patient experienced a tiny bit of redness. The reporter consented for follow up. For the tollerence of 2nd dose refer case US2019119431.
Pt c/o itchy throat. Then developed hives all over. EPI-PEN Jr was administered.
Fever 102.3F, dizziness. Treatment- monitor temperature and within 1 hrs had dropped to 101.3.
Irregular shaped, red, 2 to 4 mm in diameter, non-itchy rash appeared on patient's chest and has spread to abdomen, back and under arms.
Left arm very sore I can finally move it today  low grade temperature 99,5 I run 97.3  bad headache  and slight sore throat!
Site: Pain at Injection Site-Medium, Additional Details: Patient has difficulty lifting are past chest level. Suggest ice and heat andapplication of diclofenac gel